An official website of the United States Government 
Here's how you know

第1 🐟中石化软件下载中心网址

第2 🐟中国石化移动应用中心

第3 🐟中石化软件app

Official websites use .gov

.gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( lock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Working hard to be Edwards th中石化软件下载中心e Great

Minnesota Timberwolves guard Anthony Edwards (5) sets the play while defended by New York Knicks guard/forward Mikal Bridges (25) during the first half at Madison Square Garden, in New York, the US, Oct 9, 2025. [Photo/Agencies]

Anthony Edward中石化软件下载中心s devoted much of his previous two offseasons to the US national team for the World Cup and the Olympics, coming off intense runs through the NBA playoffs with the Minnesota Timberwolves.

As valuable as those experiences were for his flourishing career, the time Edwards had for his own training this past summer was instrumental toward his desired development into a true MVP candidate and a legitimate title contender.

"I feel like I was able to actually work on my game," he said.

For all he's done on the court over his first five seasons in the league, Edwards is still a 24-year-old with plenty of room to improve. As Timberwolves player development coach Chris Hines has told him often, "greatness is boring", a maxim seemingly tailor-made for Edwards.

"There was a lot of boring days in the gym, just working on one-dribble pull-ups," he said. "But I think it benefits me."

In the annual 中石化软件下载中心preseason survey of NBA general managers, Edwards was the runaway winner in voting for the best shooting guard in the league with a 70 percent share. But that doesn't mean he's the most complete player in that star-studded position.

Related Stories

NEWS |

first seven months of 2025

am, drives growth
NEWS |

development has made strides in

says chief executive
NEWS |

d in speedboat capsizing near Ba

African centra
NEWS |

evate financial support for new

EU pharma companies